Strategic Partnerships
Building Reliable Relationships with Pharmaceutical Leaders
Our partnership model is built around long-term supply confidence. We are not seeking transactional buyers — we are seeking pharmaceutical partners who understand the value of a documented, compliant, first-mover supply chain from West Africa.
25 kg
Minimum Order Quantity
EU · CA
Primary Export Markets
5
Business Days Response
NDA
Available for Confidential Discussions
Why Partner with HMF
Strategic Advantages for Pharmaceutical Supply Chains
Advantage 01
Consistent Supply Capacity
50,000 kg annual pilot capacity with a defined multi-year expansion roadmap. Partners can plan supply commitments knowing our production infrastructure is designed to scale alongside volume requirements.
Advantage 02
Strict Quality Standards
Full GACP implementation and active EU-GMP development programme. Every batch is third-party tested with complete COA and batch record documentation — audit-ready from day one.
Advantage 03
Competitive Pricing
Ghana’s equatorial climate, available land, and lower operational costs enable pharmaceutical-grade production at a meaningful cost advantage over European competitors.
Advantage 04
Scalable Production
Operations are structured to grow from pilot to commercial scale. Long-term supply agreements can be structured against our confirmed landholding and expansion capacity.
Advantage 05
International Compliance Expertise
In-depth knowledge of export and import regulatory requirements for EU, Canada, UK, and Australia. Our team manages the full compliance documentation package for each shipment.
Advantage 06
Complete Traceability
Quality Assurance & Compliance (GACP/GMP) at every stage — from seed to shipment. Every lot traceable to cultivation date, location, batch, input records, and test results. Every lot can be traced back to cultivation date, location, batch, input records, and testing results — meeting all pharmaceutical supplier qualification requirements.
Who We Partner With
Organisations We Serve
Our focus is exclusively on organisations operating in the medical, pharmaceutical, and research sectors.
💊
Licensed Pharmaceutical Manufacturers
Companies developing and producing cannabis-based medications — from traditional formulations to novel drug delivery systems requiring high-quality, consistently profiled raw materials.
🔬
Medical Research Institutions
Universities, research centres, and clinical trial organisations studying the therapeutic applications of cannabis compounds. We provide documented research-grade materials with full analytical data.
🏭
Pharmaceutical API Producers
Manufacturers of active pharmaceutical ingredients seeking high-quality cannabis source materials for cannabinoid isolation, refinement, and formulation into pharmaceutical-grade APIs.
📈
Series A Investors
Initial capital secured. We are actively raising our Series A targeting cannabis-specialist funds, Africa impact investors, and strategic pharmaceutical partners. We welcome formal investor introductions and can arrange briefings with the founding team.
Supply Confidence
"A Compliant African Supply Chain Is No Longer a Future Possibility — It Exists Now."
Ghana’s regulatory framework is active. Our licence is live. The window to establish first-mover supply relationships is open today — and it will not stay open indefinitely.
Partnership Process
Six Steps from Inquiry to First Shipment
A structured process designed to ensure regulatory alignment and mutual confidence before any supply commitment is made.
01
Initial Inquiry
Complete our B2B inquiry form or contact the partnerships team directly to share your requirements, volume expectations, and target timelines.
02
Consultation Discussion
Our team arranges a detailed consultation to understand your specifications, compliance requirements, cannabinoid profile preferences, and supply chain structure.
03
Partner Qualification
Mutual due diligence to verify regulatory licences, business objectives alignment, and confirm that both parties meet the compliance standards required for a pharmaceutical supply relationship.
04
Product Sampling
Where applicable, we provide validated samples with full analytical data for your independent testing, qualification protocols, and internal approval processes.
05
Supply Agreement
Formal offtake agreement covering product specifications, volumes, pricing, quality control acceptance criteria, documentation requirements, and delivery terms.
06
Logistics & First Shipment
Operational implementation including cold chain management, export documentation, customs compliance, and real-time shipment tracking through to delivery and acceptance.
Begin a Partnership Inquiry
Contact our partnerships team directly or use the inquiry form to initiate a formal introduction.
Partnerships
General Inquiries
Response Time
Within 5 business days
Regulatory
Licensed & Documented
NACOC licence, GACP implementation, and full batch documentation mean your supplier qualification process is supported at every step — not just at the point of export.
Commercial
First-Mover Pricing
Partners who establish supply relationships now benefit from preferential pricing structures as we scale from pilot to full commercial production. Locking in terms early has structural advantages.
Strategic
Supply Diversification
An African-origin licensed supply chain is a genuine supply diversification opportunity for EU and Canadian manufacturers currently dependent on European or Canadian producers.
The Right Partner Changes Everything
We are selective about the relationships we build. If you are serious about pharmaceutical cannabis supply, we want to hear from you.